Cloud-Based HIV Registry, Oxford Nanopore Catalogs Structural Variants, More
May 26, 2022 | Proscia launches an automated quality-control application that leverages artificial intelligence to improve drug development; an end-to-end software and data management package aids antibody discovery; ArisGlobal acquires BI’s analytic system; a data cloud is used for increased statistical analysis efficiency; new products from SCIEX and Dotmatics, and more.
The HIV Vaccine Trials Network, funded by the National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health (NIH), launched a new human immunodeficiency virus (HIV) awareness campaign and the Red Ribbon Registry to help end HIV. Built by Oracle, the unique cloud-based registry makes it easy for anyone to be considered for an HIV clinical study. The registry expands on Oracle’s work with the NIH and Fred Hutchinson Cancer Center throughout the COVID-19 pandemic. In addition, Oracle developed the COVID-19 Prevention Network Volunteer Screening Registry to capture and analyze nearly 700,000 participant registrations for COVID-19 vaccine and therapeutics clinical studies in just six months. Press release.
Yseop, an AI software company and pioneer in Natural Language Processing, announced a strategic collaboration with Eli Lilly. This collaboration allows Lilly to deploy Yseop’s world-class enterprise automation platform, Augmented Analyst, to accelerate bringing Lilly’s medicines to patients. With the agreement, Lilly will leverage Yseop’s Augmented Analyst to transform data into high-quality narratives and regulatory submission reports at scale and error-free. In addition to quality improvements, Yseop empowers users to focus their time on more impactful initiatives. Together, both companies will further develop the Yseop automation platform to expedite the drug approval process to realize time and cost efficiencies for Lilly. Press release.
Proscia, a digital and computational pathology solutions company, introduced an automated quality control application that leverages artificial intelligence (AI) to improve quality and efficiency in data-driven drug development. The company has also released an updated version of its Concentriq for Research platform to unify global pathology operations further and centralize data across the connected enterprise. Automated quality control leverages AI that has been trained and tested on thousands of samples to find commonly occurring quality issues in every image of H&E stained slides. Reducing the need to review these images manually drives significant productivity and quality gains that may enable research teams to start studies faster, increase the reproducibility of results, and reduce technician burnout. Press release.
FUJIFILM Healthcare Americas Corporation, a provider of enterprise imaging and informatics solutions, announced that RAYUS Radiology, one of the nation’s providers of advanced diagnostic and interventional radiology, has selected Fujifilm’s Synapse® Enterprise Information System (EIS) as the workflow management solution for its comprehensive network of over 150 imaging centers across the United States. Synapse EIS is a complete workflow management solution designed with Fujifilm’s Synapse Radiology Information System (RIS) as the foundation. The robust solution delivers enhanced workflow efficiencies, real-time administrative dashboards, and patient and provider engagement interaction tools to support RAYUS’s national network. Press release.
Oxford Nanopore announced sequencing technology to sequence 500 samples in the 1,000 Genomes Project. Their goal is to gain more scientific insights from the comprehensive genomic dataset and to create a catalog of structural variation (SV) from a diverse set of individuals. The aim is to make discoveries by uncovering SVs across the sample set. Further insights will be gained in forming links between genotype and phenotype when SVs have been implicated. In addition to studying the canonical four bases, methylation and other epigenetic modifications can be routinely produced without additional sample preparation techniques. Press release.
Suvoda, a global clinical trial technology company specializing in complex studies in therapeutic areas such as oncology, central nervous system, and rare diseases, announced they agreed to partner with N-SIDE. This deep tech company empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources. Suvoda’s IRT enables the implementation of optimized resupply strategies with adapted IRT algorithms that seamlessly integrate N-SIDE’s forecasting and mathematical optimization recommendations. This integration results in significant cost savings through reduced drug wastage and accelerated trial timelines. Press release.
SCIEX, a global life science analytical technologies company, launched the RNA 9000 Purity & Integrity kit for the BioPhase 8800 and PA 800 Plus systems. This kit is a purpose-built, high-resolution analysis method for mRNA therapeutics. It was specifically designed to provide higher resolution for mRNA therapeutics from 50 to 9,000 bases. As a result, scientists could minimize time to market with exceptional reproducibility and detect low-level impurities in samples. Press release.
ArisGlobal has acquired Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS). The engine will operate under the name of LifeSphere Clarity. It will play a key role in driving industry-wide pharmacovigilance and patient safety advancement. LifeSphere Clarity is a digital engine that leverages automation and artificial intelligence to consolidate patient safety data, reveals possible reasons why things happened, and allows modeling the potential impact of different influences. Press release.
Dotmatics, a research and development scientific software company connecting science, data, and decision-making, announced the release of its Biology Solution for Antibody Discovery: a unique end-to-end software and data management package. The antibody workflow combines Dotmatics’ enterprise scientific platform with advanced applications software used routinely in antibody discovery laboratories, including Geneious, SnapGene, and GraphPad Prism. The fully integrated solution will streamline data collection and processing of the antibody discovery workflow, facilitating a pathway to more effective and efficient discovery, and accelerating progress toward potentially life-changing therapies for patients. Press release.
Hammerspace announced that it joined the Global Alliance for Genomics and Health, GA4GH. In doing so, they partner with more than 600 of the world’s leading healthcare, research, patient advocacy, life science, and information technology organizations to create the frameworks and standards for sharing genomic and health-related data. Hammerspace decentralizes workflows to a single Global Data Environment to accelerate time for insights, collaboration, and data sharing. With Hammerspace, organizations can meet all their data storage, management, and protection requirements within a single data environment. Press release.
eClinical Solutions, a digital clinical software company, launched and demonstrated the elluminate Statistical Computing Environment (SCE). SCE is a validated environment for statistical analysis and reporting. Integrated with the elluminate Clinical Data Cloud, the SCE provides one centralized place for all data, metadata, programs, and results, increasing statistical analyses' efficiency, traceability, and visibility. With elluminate SCE, programmers and statisticians can develop and maintain programs and scripts from popular programming languages and execute those programs against data within the platform. Press release.
